Madonna's facialist in residence at Terme di Saturnia Spa & Golf Resort (Italie)
|
|
Madonna's facialist in residence at Terme di Saturnia Spa & Golf Resort (Italie)
|
Catégorie : Europe - Italie -
Ceci est un communiqué de presse sélectionné par notre comité éditorial et mis en ligne gratuitement le 06-08-2010
Michelle Peck to reveal secrets of A-list skin at Europe’s finest wellness retreat
From 21 to 27 August Michelle Peck, renowned facialist to Hollywood icons including Madonna, Gwyneth Paltrow and Eva Longoria, will take up residence at Terme di Saturnia Spa & Golf Resort in the rolling Maremma hills of Tuscany to offer guests the benefit of her extraordinary expertise as the world’s leading practitioner of the pioneering Intraceuticals Oxygen® Infusion treatment – the secret behind many stars’ stellar skin.
Michelle’s visit is the first of an ongoing collaboration with Terme di Saturnia, whereby guests will have a unique opportunity to learn the secrets of red carpet skin experience the exclusive Intraceuticals Oxygen® Infusion, the innovative treatment which uses hyperbaric oxygen to deliver hyaluronic acid, vitamins and antioxidants painlessly and naturally into the skin, without the use of needles or injections. The treatment deeply hydrates to leave the face and décolletage radiant and firm with visible lift and immediate toning.
Having worked behind the scenes at some of the world’s most glamorous fashion catwalks and showbiz events from Cannes and Los Angeles to New York and Paris, Michelle’s expertise and holistic, healthy philosophy of life makes for a natural partnership with Terme di Saturnia Spa & Golf Resort, itself a star of the hot spring world that embodies a culture of wellbeing founded on both the desire to escape and treat illness, and the will to rejuvenate and enjoy every second of life to the full.
Michelle is considered the world’s leading Intraceuticals practitioner, having pioneered its use for four years with A-list clients from Madonna to Justin Timberlake. Created in Australia in 2001, Intraceuticals derives from hyperbaric oxygen therapy – originally developed to treat a series of medical conditions.
|
|
